> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cordis Class 1 Recall of Angioguard System
- URL: https://www.fdaweb.com/cordis-class-1-recall-of-angioguard-system/
- Published: 2023-05-12T12:00:00.000Z
- Updated: 2026-09-14T18:31:39.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5154440

Cordis has recalled (Class 1) its Angioguard RX/XP Emboli Capture Guidewire System due to device separation concerns. “There is a potential for separation of the Angioguard RX/XP delivery system and capture sheath,” a [recall notice](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=199220&ref=fdaweb.com) says, which could lead to an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke.

This single-use percutaneous catheter system is introduced into an artery through the skin using a guidewire. The catheter has an embolic capture filter or an occlusion balloon at the distal end. The filter or balloon is used to capture embolic material in a manner that may protect or prevent a stroke or other cerebral vascular sequelae. It is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures.